Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature

SIMPLE SUMMARY: In advanced non-small cell lung cancer (NSCLC) patients, tumor tissue biopsy represents the gold standard for molecular analysis procedures. However, to achieve the necessary information, both at the time of diagnosis and progressive disease, is sometimes challenging, considering the...

Descripción completa

Detalles Bibliográficos
Autores principales: Verzè, Michela, Minari, Roberta, Gnetti, Letizia, Bordi, Paola, Leonetti, Alessandro, Cosenza, Agnese, Ferri, Leonarda, Majori, Maria, De Filippo, Massimo, Buti, Sebastiano, Gasparro, Donatello, Nizzoli, Rita, Azzoni, Cinzia, Bottarelli, Lorena, Squadrilli, Anna, Mozzoni, Paola, Tiseo, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582482/
https://www.ncbi.nlm.nih.gov/pubmed/34771566
http://dx.doi.org/10.3390/cancers13215403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582482/
https://www.ncbi.nlm.nih.gov/pubmed/34771566
http://dx.doi.org/10.3390/cancers13215403

Ejemplares similares